Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4797 Reports

🤖 AI Analyzed

Recent

📄 Page 246 of 400

Inland Real Estate Income Trust, Inc.

10-K March 11, 2026

Key Highlights

IREIT reported stable financial performance in 2023 with total revenues up 3.5% ...
The company maintained a strong 93.2% occupancy rate and achieved an average 5.5...
Strategic achievements include acquiring two grocery-anchored centers for $45 mi...

Read Analysis

🤖 AI Generated

Stellus Capital Investment Corp

10-K March 11, 2026

Key Highlights

Strong Net Investment Income (NII) growth to $2.05 per share in 2023, driven by ...
Significant investment portfolio expansion to $950 million, fueled by $210 milli...
High proportion of floating-rate debt investments (95%) benefits from a higher i...

Read Analysis

🤖 AI Generated

First Internet Bancorp

10-K March 11, 2026

Key Highlights

Achieved robust loan growth of 12% to $3.5 billion and deposit growth of 10% to ...
Delivered strong financial performance with Net Income up 10.5% to $42 million a...
Maintained healthy capital ratios (Tier 1 at 12.5%, Total at 14.8%) and strong l...

Read Analysis

🤖 AI Generated

KAMADA LTD

20-F March 11, 2026

Key Highlights

KAMADA LTD specializes in plasma-derived therapeutics, with clear descriptions o...
The company provides strong financial projections for 2026, building on its 2025...
KAMADA leverages its competitive advantages in niche markets and capitalizes on ...

Read Analysis

🤖 AI Generated

JPMBB Commercial Mortgage Securities Trust 2013-C12

10-K March 11, 2026

Key Highlights

Consistent compliance of key servicers (Midland, LNR, Wells Fargo, Pentalpha) wi...
Original loan portfolio was diversified, with no single loan exceeding 10% of to...
The trust's structure is transparent, with investment performance directly refle...

Read Analysis

🤖 AI Generated

Minerva Neurosciences, Inc.

10-K March 11, 2026

Key Highlights

Roluperidone advancing towards FDA New Drug Application (NDA) submission, a crit...
Successfully completed a private placement in October and December 2025, raising...
Cash and cash equivalents of $35.0 million as of December 31, 2025, with an esti...

Read Analysis

🤖 AI Generated

Evofem Biosciences, Inc.

10-K March 11, 2026

Key Highlights

Phexxi sales increased by a modest 5% to $25 million in 2024, driven by higher p...
Net loss improved significantly from $110 million in 2023 to $80 million in 2024...
Phexxi offers a unique non-hormonal, on-demand option in the competitive women's...

Read Analysis

🤖 AI Generated

Verrica Pharmaceuticals Inc.

10-K March 11, 2026

Key Highlights

FDA approval of YCANTH in July 2023, marking the first FDA-approved treatment fo...
Successful initial commercial launch of YCANTH in September 2023, generating $5....
Advancement of pipeline candidates VP-102 for common warts and VP-315 for basal ...

Read Analysis

🤖 AI Generated

Highlands REIT, Inc.

10-K March 11, 2026

Key Highlights

Strategic portfolio streamlining with the sale of non-core industrial assets in ...
Diversified property portfolio comprising 5 multifamily and 5 commercial propert...
Proactive use of interest rate swaps to hedge against rising interest rates on s...

Read Analysis

🤖 AI Generated

Target Hospitality Corp.

10-K March 11, 2026

Key Highlights

Total revenue increased 25% year-over-year to $550 million, with Adjusted EBITDA...
Secured significant contract expansions in the Government segment and maintained...
Strategic growth initiatives include a new multi-year lease (26 months) and an e...

Read Analysis

🤖 AI Generated

PLIANT THERAPEUTICS, INC.

10-K March 11, 2026

Key Highlights

Advancing PLN-74809 into Phase 2 trials for IPF and PSC, with data readouts anti...
Strategic collaboration with Novartis effective in 2025, providing significant v...
Strong cash position of approximately $350 million, providing a projected cash r...

Read Analysis

🤖 AI Generated

VINEBROOK HOMES TRUST, INC.

10-K March 11, 2026

Key Highlights

Strong financial performance with 12% revenue growth to $550 million and 15% AFF...
Robust operational metrics including a 97% occupancy rate, 6% average rent growt...
Positive future outlook with plans for 6-8% portfolio growth, 4-6% same-store re...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage